MRPS21
gene geneOn this page
Also known as bS21m
Summary
MRPS21 (mitochondrial ribosomal protein S21, HGNC:14046) is a protein-coding gene on chromosome 1q21.2, encoding Small ribosomal subunit protein bS21m (P82921). It is a common-essential gene (DepMap: required in 97.4% of cancer cell lines).
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 28S subunit protein that belongs to the ribosomal protein S21P family. Pseudogenes corresponding to this gene are found on chromosomes 1p, 1q, 9p, 10p, 10q, 16q, and 17q. Available sequence data analyses identified splice variants that differ in the 5’ UTR; both transcripts encode the same protein.
Source: NCBI Gene 54460 — RefSeq curated summary.
At a glance
- GWAS associations: 19
- Clinical variants (ClinVar): 25 total
- GTEx eGene: eQTL in 46 tissues, sQTL in 28 (q < 0.05)
- Cancer dependency (DepMap): dependent in 97.4% of screened cell lines (common-essential)
- Constraint (gnomAD): pLI 0.02 (LoF-tolerant), LOEUF 1.61 (unconstrained)
- MANE Select transcript:
NM_031901 - Interaction hub: 1,777 STRING partners (top 10% of genes corpus-wide)
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14046 |
| Approved symbol | MRPS21 |
| Name | mitochondrial ribosomal protein S21 |
| Location | 1q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bS21m |
| Ensembl gene | ENSG00000266472 |
| Ensembl biotype | protein_coding |
| OMIM | 611984 |
| Entrez | 54460 |
Gene structure
Transcript identifiers
Ensembl transcripts: 27 — 22 protein_coding, 5 nonsense_mediated_decay
MANE Select: ENST00000614145
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 2
ENST00000614145, ENST00000581066, ENST00000877736, ENST00000877737, ENST00000877738, ENST00000877739, ENST00000935111, ENST00000935112, ENST00000935113, ENST00000935114, ENST00000935115, ENST00000935116, ENST00000935117, ENST00000935118, ENST00001097046, ENST00001097047, ENST00001097048, ENST00001097049, ENST00001097050, ENST00001097051, ENST00001097052, ENST00001097053, ENST00001097054, ENST00001097055, ENST00001097056, ENST00001097057, ENST00001145401
RefSeq mRNA: 2 — MANE Select: NM_031901
NM_018997, NM_031901
CCDS: CCDS950
Canonical transcript exons
ENST00000614145 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002710928 | 150308048 | 150308979 |
| ENSE00003716402 | 150293861 | 150293898 |
| ENSE00003734455 | 150294335 | 150294449 |
Expression profiles
Bgee: expression breadth ubiquitous, 255 present calls, max score 98.66.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 84.5425 / max 1019.3506, expressed in 1824 samples.
Highest expression (Bgee): cardiac muscle of right atrium, ventricle myocardium, lateral nuclear group of thalamus, pons, sperm.
Genetic regulation across tissues (GTEx eQTL / sQTL)
MRPS21 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 46 tissues and its splicing (sQTL) in 28 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
showing 20 of 74 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Thyroid | eqtl | 9.2e-62 | -0.43 | 1:150293918:T:A |
| Esophagus Muscularis | eqtl | 2.9e-34 | +0.30 | 1:150501861:G:A |
| Pituitary | eqtl | 7.8e-34 | -0.55 | 1:150293918:T:A |
| Nerve Tibial | eqtl | 9.2e-33 | -0.27 | 1:150293918:T:A |
| Muscle Skeletal | eqtl | 6.2e-32 | -0.28 | 1:150291686:C:T |
| Heart Atrial Appendage | eqtl | 3.1e-30 | +0.37 | 1:150479023:G:C |
| Testis | eqtl | 6.1e-30 | +0.44 | 1:150323220:G:A |
| Lung | eqtl | 4.5e-25 | -0.29 | 1:150293918:T:A |
| Skin Sun Exposed Lower leg | eqtl | 2.3e-20 | -0.23 | 1:150293918:T:A |
| Heart Left Ventricle | eqtl | 2.8e-20 | +0.29 | 1:150494449:C:T |
| Testis | sqtl | 2.6e-19 | +0.94 | 1:150308908:C:T |
| Esophagus Gastroesophageal Junction | eqtl | 2.2e-18 | +0.28 | 1:150494261:A:G |
| Colon Sigmoid | eqtl | 4.4e-18 | +0.32 | 1:150396861:G:A |
| Skin Not Sun Exposed Suprapubic | eqtl | 6.0e-18 | -0.24 | 1:150293918:T:A |
| Adipose Visceral Omentum | eqtl | 2.3e-17 | +0.24 | 1:150479356:G:A |
| Artery Aorta | eqtl | 4.1e-16 | -0.23 | 1:150291686:C:T |
| Whole Blood | eqtl | 7.3e-16 | -0.15 | 1:150293918:T:A |
| Cells Cultured fibroblasts | eqtl | 7.4e-16 | +0.32 | 1:150325557:C:T |
| Breast Mammary Tissue | eqtl | 1.9e-15 | +0.21 | 1:150393993:C:A |
| Pituitary | sqtl | 1.1e-14 | +0.54 | 1:150526339:A:G |
FANTOM5 promoters
2 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 5089 | 84.0442 | 1824 |
| 5090 | 0.4983 | 254 |
Top tissues by expression
showing 100 of 256 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cardiac muscle of right atrium | UBERON:0003379 | 98.66 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 98.60 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 98.43 | gold quality |
| pons | UBERON:0000988 | 98.37 | gold quality |
| sperm | CL:0000019 | 98.30 | gold quality |
| myocardium | UBERON:0002349 | 98.21 | gold quality |
| pancreatic ductal cell | CL:0002079 | 98.14 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 98.06 | gold quality |
| kidney epithelium | UBERON:0004819 | 98.06 | gold quality |
| upper arm skin | UBERON:0004263 | 97.98 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 97.53 | gold quality |
| renal medulla | UBERON:0000362 | 97.51 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 97.40 | gold quality |
| adult organism | UBERON:0007023 | 97.38 | gold quality |
| cerebellar vermis | UBERON:0004720 | 97.37 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 97.36 | gold quality |
| vena cava | UBERON:0004087 | 97.35 | gold quality |
| seminal vesicle | UBERON:0000998 | 97.32 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 97.32 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 97.21 | gold quality |
| hypothalamus | UBERON:0001898 | 97.15 | gold quality |
| ventral tegmental area | UBERON:0002691 | 97.10 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 97.09 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 97.03 | gold quality |
| trachea | UBERON:0003126 | 97.03 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 97.03 | gold quality |
| superior surface of tongue | UBERON:0007371 | 96.98 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 96.98 | gold quality |
| body of tongue | UBERON:0011876 | 96.96 | gold quality |
| tongue | UBERON:0001723 | 96.95 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 96.94 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 96.91 | gold quality |
| pericardium | UBERON:0002407 | 96.88 | gold quality |
| medulla oblongata | UBERON:0001896 | 96.86 | gold quality |
| pylorus | UBERON:0001166 | 96.85 | gold quality |
| nucleus accumbens | UBERON:0001882 | 96.85 | gold quality |
| bronchus | UBERON:0002185 | 96.80 | gold quality |
| bronchial epithelial cell | CL:0002328 | 96.78 | gold quality |
| oral cavity | UBERON:0000167 | 96.76 | gold quality |
| putamen | UBERON:0001874 | 96.75 | gold quality |
| amygdala | UBERON:0001876 | 96.72 | gold quality |
| adrenal cortex | UBERON:0001235 | 96.71 | gold quality |
| caudate nucleus | UBERON:0001873 | 96.67 | gold quality |
| midbrain | UBERON:0001891 | 96.65 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 96.64 | gold quality |
| substantia nigra | UBERON:0002038 | 96.62 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 96.59 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 96.59 | gold quality |
| heart right ventricle | UBERON:0002080 | 96.54 | gold quality |
| adenohypophysis | UBERON:0002196 | 96.54 | gold quality |
| urethra | UBERON:0000057 | 96.53 | gold quality |
| left adrenal gland | UBERON:0001234 | 96.52 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 96.51 | gold quality |
| gingiva | UBERON:0001828 | 96.51 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 96.51 | gold quality |
| thymus | UBERON:0002370 | 96.50 | gold quality |
| pituitary gland | UBERON:0000007 | 96.49 | gold quality |
| prefrontal cortex | UBERON:0000451 | 96.49 | gold quality |
| saphenous vein | UBERON:0007318 | 96.49 | gold quality |
| forebrain | UBERON:0001890 | 96.46 | gold quality |
| gingival epithelium | UBERON:0001949 | 96.46 | gold quality |
| right adrenal gland | UBERON:0001233 | 96.45 | gold quality |
| neocortex | UBERON:0001950 | 96.45 | gold quality |
| primary visual cortex | UBERON:0002436 | 96.45 | gold quality |
| occipital lobe | UBERON:0002021 | 96.44 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 96.44 | gold quality |
| cardiac atrium | UBERON:0002081 | 96.43 | gold quality |
| cerebral cortex | UBERON:0000956 | 96.42 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 96.40 | gold quality |
| decidua | UBERON:0002450 | 96.40 | gold quality |
| frontal cortex | UBERON:0001870 | 96.37 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 96.37 | gold quality |
| cortical plate | UBERON:0005343 | 96.36 | gold quality |
| synovial joint | UBERON:0002217 | 96.35 | gold quality |
| penis | UBERON:0000989 | 96.28 | gold quality |
| right frontal lobe | UBERON:0002810 | 96.28 | gold quality |
| right atrium auricular region | UBERON:0006631 | 96.27 | gold quality |
| caput epididymis | UBERON:0004358 | 96.25 | gold quality |
| temporal lobe | UBERON:0001871 | 96.21 | gold quality |
| metanephros | UBERON:0000081 | 96.19 | gold quality |
| brain | UBERON:0000955 | 96.19 | gold quality |
| mammalian vulva | UBERON:0000997 | 96.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 96.08 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 96.07 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 96.02 | gold quality |
| heart | UBERON:0000948 | 96.01 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 95.98 | silver quality |
| cardiac ventricle | UBERON:0002082 | 95.96 | gold quality |
| heart left ventricle | UBERON:0002084 | 95.94 | gold quality |
| corpus epididymis | UBERON:0004359 | 95.94 | gold quality |
| cortex of kidney | UBERON:0001225 | 95.89 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 95.89 | gold quality |
| mammary duct | UBERON:0001765 | 95.87 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 95.87 | gold quality |
| Ammon’s horn | UBERON:0001954 | 95.86 | gold quality |
| ganglionic eminence | UBERON:0004023 | 95.86 | gold quality |
| islet of Langerhans | UBERON:0000006 | 95.82 | gold quality |
| adrenal gland | UBERON:0002369 | 95.82 | gold quality |
| nipple | UBERON:0002030 | 95.78 | gold quality |
| apex of heart | UBERON:0002098 | 95.78 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8559 | no | 1029.92 |
| E-ANND-3 | no | 0.00 |
HPA expression
RNA tissue specificity: Low tissue specificity
showing 60 of 76 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM |
|---|---|---|
| Caudate putamen | tissue | 231.4 |
| Frontal cortex | tissue | 195.9 |
| Postcentral gyrus | tissue | 71.7 |
| Ovary | tissue | 70.6 |
| Pituitary gland | tissue | 69.7 |
| Choroid plexus | tissue | 69.7 |
| Tongue | tissue | 62.1 |
| Parathyroid gland | tissue | 61.5 |
| Adrenal gland | tissue | 58.7 |
| Nucleus accumbens | tissue | 58.5 |
| Locus coeruleus | tissue | 57.6 |
| Heart muscle | tissue | 56.5 |
| Epididymis | tissue | 50.7 |
| Hippocampus | tissue | 50.7 |
| Skeletal muscle | tissue | 49.7 |
| Breast | tissue | 48.4 |
| Kidney | tissue | 46.9 |
| Vagina | tissue | 46.7 |
| Thymus | tissue | 45.6 |
| Liver | tissue | 44.9 |
| Tonsil | tissue | 43.7 |
| Fallopian tube | tissue | 41.8 |
| Urinary bladder | tissue | 41.5 |
| Thyroid gland | tissue | 41.1 |
| Lymph node | tissue | 39.9 |
| Adipose tissue | tissue | 39.6 |
| Retina | tissue | 39.2 |
| Seminal vesicle | tissue | 36.9 |
| Stomach 1 | tissue | 36.8 |
| Bone marrow | tissue | 36.7 |
| Spleen | tissue | 36.6 |
| Endometrium 1 | tissue | 36.4 |
| Smooth muscle | tissue | 36.2 |
| Duodenum | tissue | 36.0 |
| Salivary gland | tissue | 35.9 |
| Appendix | tissue | 33.7 |
| Pancreas | tissue | 33.6 |
| Cervix | tissue | 33.5 |
| Prostate | tissue | 32.3 |
| Skin 1 | tissue | 32.2 |
| Small intestine | tissue | 32.2 |
| Placenta | tissue | 30.6 |
| Lung | tissue | 30.1 |
| Testis | tissue | 30.0 |
| Putamen | tissue | 28.4 |
| Rectum | tissue | 27.2 |
| Basal ganglia | tissue | 27.2 |
| Esophagus | tissue | 27.0 |
| Pons | tissue | 26.8 |
| Colon | tissue | 26.5 |
| Gallbladder | tissue | 25.9 |
| Spinal cord | tissue | 25.9 |
| Medulla oblongata | tissue | 25.4 |
| Superior colliculi | tissue | 25.1 |
| Periaqueductal gray | tissue | 24.7 |
| Thalamus | tissue | 24.6 |
| Midbrain | tissue | 24.4 |
| Substantia nigra | tissue | 24.1 |
| Corpus callosum | tissue | 24.0 |
| Ventral forebrain | tissue | 23.6 |
Brain sub-regions (HPA Brain Atlas): detected in 189; highest nTPM — Habenula (65.6), Paracentral lobule, anterior (65.1), Arcuate nucleus (64.7), Precentral gyrus, middle (64.5), Lateral hypothalamic area (64.0).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting MRPS21 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
30 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-2052 | 99.79 | 69.37 | 2031 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-561-3P | 99.64 | 70.90 | 3647 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-3678-3P | 99.31 | 67.10 | 1432 |
| HSA-MIR-504-3P | 99.30 | 67.18 | 1745 |
| HSA-MIR-1273H-3P | 99.29 | 67.55 | 980 |
| HSA-MIR-5693 | 99.24 | 66.67 | 1106 |
| HSA-MIR-619-5P | 98.57 | 64.97 | 1988 |
| HSA-MIR-5089-5P | 98.45 | 66.06 | 1388 |
| HSA-MIR-3166 | 98.24 | 66.63 | 1223 |
| HSA-MIR-660-5P | 98.16 | 68.27 | 680 |
| HSA-MIR-197-3P | 98.09 | 69.23 | 1004 |
| HSA-MIR-4443 | 98.02 | 66.25 | 1928 |
| HSA-MIR-5000-5P | 97.40 | 66.11 | 1055 |
| HSA-MIR-3664-5P | 96.74 | 66.56 | 770 |
| HSA-MIR-4790-3P | 96.63 | 67.08 | 806 |
| HSA-MIR-1298-3P | 94.05 | 64.84 | 620 |
Functional genomics
gnomAD constraint: pLI 0.0197, LOEUF 1.61, missense Z 0.498 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000614145 — one region, missense o/e 0.85.
DepMap (CRISPR cell-line fitness): dependent in 97.4% of screened cell lines, common-essential.
Most-dependent cell lines (DepMap gene-effect, lower = stronger; ≤ −0.5 shown): SU-DHL-10 (-2.544), SNU-620 (-2.321), COLO-678 (-2.175), COR-L279 (-2.049), LP-1 (-2.028), HUP-T4 (-1.931), NIH:OVCAR-3 (-1.917), HD-MY-Z (-1.878), G-402 (-1.827), HCC1187 (-1.821), MEL-HO (-1.793), KP-4 (-1.792), SNU-1196 (-1.791), RERF-GC-1B (-1.782), KNS-81 (-1.736).
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Mrps21 | ENSMUSG00000054312 |
| rattus_norvegicus | Mrps21 | ENSRNOG00000024845 |
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1913542) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 1 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| preweaning lethality, complete penetrance | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Bos taurus | P82920 | 95.4% | Diamond |
| Acidiphilium cryptum JF-5 | A5FVG6 | 94.0% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| CIART | protein-coding | 148523 |
| C1orf54 | protein-coding | 79630 |
| PRPF3 | protein-coding | 9129 |
| SNORD13C | snoRNA | 109616989 |
| CA14 | protein-coding | 23632 |
| APH1A | protein-coding | 51107 |
| RPRD2 | protein-coding | 23248 |
| MIR6878 | ncRNA | 102465529 |
| TARS2 | protein-coding | 80222 |
Protein
Protein identifiers
Small ribosomal subunit protein bS21m — P82921 (reviewed: P82921)
Alternative names: 28S ribosomal protein S21, mitochondrial
All UniProt accessions (1): P82921
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Component of the mitochondrial small ribosomal subunit (mt-SSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins.
Subcellular location. Mitochondrion.
Similarity. Belongs to the bacterial ribosomal protein bS21 family.
RefSeq proteins (2): NP_061870, NP_114107* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001911 | Ribosomal_bS21 | Family |
| IPR038380 | Ribosomal_bS21_sf | Homologous_superfamily |
Pfam: PF01165
UniProt features (13 total): helix 5, strand 4, sequence variant 2, chain 1, turn 1
Structure
Experimental structures (PDB)
showing 30 of 79 structures by resolution:
| PDB | Title | Method | Resolution (Å) |
|---|---|---|---|
| 8CSS | Human mitochondrial small subunit assembly intermediate (State D) | ELECTRON MICROSCOPY | 2.36 |
| 7P2E | Human mitochondrial ribosome small subunit in complex with IF3, GMPPMP and streptomycin | ELECTRON MICROSCOPY | 2.4 |
| 8RRI | Human mitochondrial ribosome in complex with antibiotic tigecycline | ELECTRON MICROSCOPY | 2.4 |
| 9OLF | Membrane-associated human mitoribosome in complex with TACO1 | ELECTRON MICROSCOPY | 2.46 |
| 9OJM | Human mitochondrial 28S PIC with tRNA and mtIF2 | ELECTRON MICROSCOPY | 2.5 |
| 8CSQ | Human mitochondrial small subunit assembly intermediate (State B) | ELECTRON MICROSCOPY | 2.54 |
| 8CSR | Human mitochondrial small subunit assembly intermediate (State C) | ELECTRON MICROSCOPY | 2.54 |
| 6ZM6 | Human mitochondrial ribosome in complex with mRNA, A/A tRNA and P/P tRNA | ELECTRON MICROSCOPY | 2.59 |
| 8CSP | Human mitochondrial small subunit assembly intermediate (State A) | ELECTRON MICROSCOPY | 2.66 |
| 7PNX | Assembly intermediate of human mitochondrial ribosome small subunit without mS37 in … | ELECTRON MICROSCOPY | 2.76 |
| 8ANY | Human mitochondrial ribosome in complex with LRPPRC, SLIRP, A-site, P-site, E-site tRNAs … | ELECTRON MICROSCOPY | 2.85 |
| 8CST | Human mitochondrial small subunit assembly intermediate (State E) | ELECTRON MICROSCOPY | 2.85 |
| 6ZM5 | Human mitochondrial ribosome in complex with OXA1L, mRNA, A/A tRNA, P/P tRNA and nascent … | ELECTRON MICROSCOPY | 2.89 |
| 7PO0 | Assembly intermediate of human mitochondrial ribosome small subunit without mS37 in … | ELECTRON MICROSCOPY | 2.9 |
| 8K2A | Cryo-EM structure of the human 55S mitoribosome with Tigecycline | ELECTRON MICROSCOPY | 2.9 |
| 9PGL | In situ structure of the human mitoribosome in the A-P state with TACO1 | ELECTRON MICROSCOPY | 2.9 |
| 9VXM | Human mitoribosome in a non-rotated state, with multiple neomycin molecules bound … | ELECTRON MICROSCOPY | 2.9 |
| 7PO1 | Initiation complex of human mitochondrial ribosome small subunit with IF3 | ELECTRON MICROSCOPY | 2.92 |
| 7PO3 | Human mitochondrial ribosome small subunit | ELECTRON MICROSCOPY | 2.92 |
| 9PGF | In situ structure of the human mitoribosome in the P state | ELECTRON MICROSCOPY | 2.93 |
| 6VMI | Structure of the human mitochondrial ribosome-EF-G1 complex (ClassIII) | ELECTRON MICROSCOPY | 2.96 |
| 6RW4 | Structure of human mitochondrial 28S ribosome in complex with mitochondrial IF3 | ELECTRON MICROSCOPY | 2.97 |
| 6VLZ | Structure of the human mitochondrial ribosome-EF-G1 complex (ClassI) | ELECTRON MICROSCOPY | 2.97 |
| 8QRN | mt-SSU in GTPBP8 knock-out cells, state 4 | ELECTRON MICROSCOPY | 2.98 |
| 9PSM | In situ structure of the human mitoribosome in the A/P-P/E state | ELECTRON MICROSCOPY | 2.98 |
| 8OIS | 28S human mitochondrial small ribosomal subunit with mtRF1 and P-site tRNA | ELECTRON MICROSCOPY | 3 |
| 9G5C | Assembly intermediate of human mitochondrial ribosome small subunit (State B) | ELECTRON MICROSCOPY | 3 |
| 9G5D | Assembly intermediate of human mitochondrial ribosome small subunit (State C) | ELECTRON MICROSCOPY | 3 |
| 9H54 | Assembly intermediate of human mitochondrial ribosome small subunit in complex with NOA1 … | ELECTRON MICROSCOPY | 3 |
| 9HFM | Translation-initiation state of human mitochondrial ribosome small subunit (State D) | ELECTRON MICROSCOPY | 3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P82921-F1 | 96.48 | 0.96 |
Human Protein Atlas
Protein class: Ribosomal proteins, Predicted intracellular proteins, Essential proteins
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): mitochondria
Antibody reliability (HPA): IF supported
Function
Pathways and Gene Ontology
Reactome pathways
2 curated (TAS) of 7; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
7 pathways:
| ID | Pathway | Evidence |
|---|---|---|
| R-HSA-9937383 | Mitochondrial ribosome-associated quality control | curated |
| R-HSA-5419276 | Mitochondrial translation termination | curated |
| R-HSA-392499 | Metabolism of proteins | — |
| R-HSA-5368287 | Mitochondrial translation | — |
| R-HSA-5389840 | Mitochondrial translation elongation | electronic |
| R-HSA-5368286 | Mitochondrial translation initiation | electronic |
| R-HSA-72766 | Translation | — |
MSigDB gene sets: 115 (showing top):
PAL_PRMT5_TARGETS_UP, GOBP_MITOCHONDRIAL_TRANSLATION, TGACCTY_ERR1_Q2, SRF_Q5_01, GOBP_TRANSLATION, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1, WANG_LMO4_TARGETS_DN, GGAANCGGAANY_UNKNOWN, GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME, GOCC_MITOCHONDRIAL_ENVELOPE, GOCC_RIBOSOME, chr1q21, GOCC_SMALL_RIBOSOMAL_SUBUNIT, GOCC_ORGANELLAR_RIBOSOME, GOCC_MITOCHONDRIAL_MATRIX
GO Biological Process (2): translation (GO:0006412), mitochondrial translation (GO:0032543)
GO Molecular Function (2): RNA binding (GO:0003723), structural constituent of ribosome (GO:0003735)
GO Cellular Component (5): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial small ribosomal subunit (GO:0005763), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
3 top-level categories:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 4 |
| Translation | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
22 GO namespaces:
| Category | Terms |
|---|---|
| peptidyltransferase activity | 1 |
| translational initiation | 1 |
| translational elongation | 1 |
| translational termination | 1 |
| macromolecule biosynthetic process | 1 |
| protein metabolic process | 1 |
| protein biosynthetic process | 1 |
| mitochondrion | 1 |
| translation | 1 |
| mitochondrial gene expression | 1 |
| nucleic acid binding | 1 |
| structural molecule activity | 1 |
| ribosome | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| organellar small ribosomal subunit | 1 |
| mitochondrial ribosome | 1 |
| mitochondrial protein-containing complex | 1 |
| intracellular membraneless organelle | 1 |
| protein-containing complex | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 3 of 9 annotations. The rest are phylogenetic / computational / electronic (IEA).
3 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| mitochondrial small ribosomal subunit | CC | direct assay |
| mitochondrion | CC | direct assay |
| RNA binding | MF | high-throughput assay |
Protein interactions and networks
STRING
showing 16 of 1,777 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRPS21 | MRPL51 | Q4U2R6 | 620 |
| MRPS21 | MRPS15 | P82914 | 572 |
| MRPS21 | MRPL52 | Q86TS9 | 544 |
| MRPS21 | MRPL55 | Q7Z7F7 | 530 |
| MRPS21 | RBM23 | Q86U06 | 497 |
| MRPS21 | MRPS24 | P82668 | 458 |
| MRPS21 | MRPL37 | Q9BZE1 | 451 |
| MRPS21 | MRPL19 | P49406 | 442 |
| MRPS21 | EIF1B | O60739 | 441 |
| MRPS21 | RNF123 | Q5XPI4 | 438 |
| MRPS21 | SLC25A29 | Q8N8R3 | 428 |
| MRPS21 | RPS21 | P35265 | 427 |
| MRPS21 | DAP3 | P51398 | 427 |
| MRPS21 | MRPS5 | P82675 | 424 |
| MRPS21 | MRPL43 | Q8N983 | 424 |
| MRPS21 | MRPL41 | Q8IXM3 | 424 |
IntAct
BioGRID (145 interactions; top human partners by supporting records): AURKAIP1 (Affinity Capture-MS; 3 records), MRPS31 (Affinity Capture-MS; 3 records), TRMT10B (Affinity Capture-MS; 3 records), CCNF (Affinity Capture-MS; 2 records), MOV10 (Affinity Capture-RNA; 2 records), MRPS11 (Affinity Capture-MS; 2 records), MRPS15 (Affinity Capture-MS; 2 records), MRPS27 (Affinity Capture-MS; 2 records), MRPS34 (Affinity Capture-MS; 2 records), MRPS9 (Affinity Capture-MS; 2 records), RPL6 (Affinity Capture-MS; 2 records), ZC3H3 (Affinity Capture-MS; 2 records), ABT1 (Affinity Capture-MS), ACACA (Negative Genetic), APOBEC3D (Affinity Capture-MS)
SIGNOR signaling
1 signaling interactions:
| A | Effect | B | Mechanism |
|---|---|---|---|
| MRPS21 | “form complex” | “28S mitochondrial small ribosomal subunit” | binding |
Protein complexes (CORUM) (2)
Experimentally-characterized complexes this protein is a subunit of (★ = the complex contains a known drug target).
2 complexes by size:
| Complex | Subunits | Members |
|---|---|---|
| 55S ribosome, mitochondrial | 78 | MRPS30, MRPL1, MRPL14, MRPL41, MRPL45, MRPL50, MRPL54, MRPS18B, MRPS2, MRPS21, MRPS34, MRPL17, MRPS6, MRPS17, MRPS31, MRPS33, MRPL21, MRPL24, MRPS10, MRPS11, MRPL12, MRPL22, MRPL47, MRPL49, MRPS35, MRPS7, MRPL28, MRPL37, MRPL40, MRPL48, MRPS18A, MRPS22, MRPS23, MRPL13, MRPL46, MRPS28, MRPL16, MRPL23, MRPL39, MRPL52, MRPL53, MRPL19, MRPL42, MRPL44, MRPL11, MRPL2, MRPL27, MRPL33, MRPL34, MRPL35, MRPS25, MRPS26, DAP3, MRPL18, MRPL38, MRPL9, MRPS12, MRPS27, MRPS5, MRPS9, MRPL20, MRPL30, MRPL36, MRPL43, MRPS14, KGD4, MRPL32, MRPL4, MRPL51, MRPS15, MRPS16, MRPL3, MRPL55, MRPS18C, LACTB, MRPL10, MRPL15, MRPS24 |
| 28S ribosomal subunit, mitochondrial | 30 | MRPS18A, MRPS28, MRPS30, MRPS7, DAP3, MRPS11, MRPS18C, MRPS16, MRPS17, MRPS18B, MRPS23, MRPS25, MRPS9, MRPS34, MRPS31, MRPS6, KGD4, MRPS15, MRPS2, MRPS27, MRPS35, MRPS10, MRPS12, MRPS21, MRPS26, MRPS33, MRPS22, MRPS24, MRPS5, MRPS14 |
Disease & clinical
Genetic variants
Variant evidence for MRPS21: 25 ClinVar records (0 pathogenic / likely pathogenic); 19 GWAS associations.
ClinVar
25 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 12 |
| Likely benign | 1 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 15 predictions of 189):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 1:150294450–150294451 | donor_loss | 1.0000 | 5 |
| 1:150308045 | acceptor_gain | 1.0000 | |
| 1:150308047 | acceptor_loss | 1.0000 | |
| 1:150308043 | acceptor_gain | 0.9900 | |
| 1:150308047 | acceptor_loss | 0.9900 | |
| 1:150308046–150308047 | acceptor_loss | 0.9800 | 2 |
| 1:150294451 | donor_loss | 0.9700 | |
| 1:150308046 | acceptor_loss | 0.9700 | |
| 1:150308046 | acceptor_loss | 0.9600 | |
| 1:150295543 | donor_gain | 0.9500 |
AlphaMissense
65 missense substitutions predicted likely pathogenic (of 578 scored), across 31 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| M68 | 6 | 0.658 | 0.714 |
| F7 | 4 | 0.864 | 0.935 |
| F74 | 4 | 0.815 | 0.867 |
| W84 | 4 | 0.716 | 0.742 |
| R54 | 4 | 0.698 | 0.783 |
| R10 | 4 | 0.692 | 0.741 |
| E46 | 4 | 0.666 | 0.750 |
| K71 | 3 | 0.719 | 0.779 |
| K47 | 3 | 0.698 | 0.734 |
| L30 | 3 | 0.689 | 0.789 |
| A22 | 2 | 0.699 | 0.804 |
| T11 | 2 | 0.644 | 0.713 |
| C60 | 2 | 0.643 | 0.675 |
| E67 | 2 | 0.642 | 0.661 |
| L26 | 2 | 0.627 | 0.677 |
| V12 | 1 | 0.777 | 0.777 |
| R52 | 1 | 0.758 | 0.758 |
| R70 | 1 | 0.718 | 0.718 |
| R62 | 1 | 0.716 | 0.716 |
| A9 | 1 | 0.641 | 0.641 |
HPA cancer prognostics
RNA cancer specificity: Low cancer specificity
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
1 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Liver Hepatocellular Carcinoma (TCGA) | unfavorable | 0.000164 |
Disease associations
OMIM: gene MIM:611984 | disease phenotypes:
GWAS associations
19 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST010700_28 | Cortical thickness (MOSTest) | 8e-38 |
| GCST010696_2 | Cortical thickness (min-P) | 2e-23 |
| GCST008059_87 | Estimated glomerular filtration rate | 3e-19 |
| GCST010002_27 | Refractive error | 3e-15 |
| GCST010701_57 | Cortical surface area (MOSTest) | 9e-12 |
| GCST010703_294 | Brain morphology (MOSTest) | 9e-12 |
| GCST90020028_1240 | Hip circumference adjusted for BMI | 9e-11 |
| GCST012332_7 | Multisite chronic pain | 1e-10 |
| GCST008747_38 | Estimated glomerular filtration rate | 3e-10 |
| GCST005038_66 | Allergic disease (asthma, hay fever or eczema) | 1e-9 |
| GCST010702_101 | Subcortical volume (MOSTest) | 4e-9 |
| GCST003184_16 | Atopic dermatitis | 5e-9 |
| GCST004946_34 | Schizophrenia | 5e-9 |
| GCST008745_3 | Estimated glomerular filtration rate in non-diabetics | 5e-9 |
| GCST010697_28 | Cortical surface area (min-P) | 9e-9 |
| GCST010698_54 | Subcortical volume (min-P) | 2e-8 |
| GCST011352_36 | Alanine aminotransferase levels | 2e-8 |
| GCST010699_28 | Brain morphology (min-P) | 3e-8 |
| GCST003184_26 | Atopic dermatitis | 1e-7 |
EFO canonical traits (from GWAS)
4 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0004346 | neuroimaging measurement |
| EFO:0004840 | cortical thickness |
| EFO:0010100 | multisite chronic pain |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| chloropicrin | affects expression, decreases expression | 2 |
| Leflunomide | decreases expression | 2 |
| Acetaminophen | decreases expression, increases expression, affects cotreatment | 2 |
| bisphenol A | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| methylparaben | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| isobutyl alcohol | affects cotreatment, decreases expression, increases abundance | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| jinfukang | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Estradiol | decreases expression | 1 |
| Gasoline | affects cotreatment, decreases expression, increases abundance | 1 |
| Ivermectin | decreases expression | 1 |
| Lipopolysaccharides | affects cotreatment, decreases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Polycyclic Aromatic Hydrocarbons | affects cotreatment, decreases expression, increases abundance | 1 |
| Ribonucleotides | affects binding | 1 |
| Smoke | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Lactic Acid | decreases expression | 1 |
| Particulate Matter | affects cotreatment, decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): allergic disease, atopic eczema